Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
BMJ Case Rep ; 14(8)2021 Aug 03.
Article in English | MEDLINE | ID: mdl-34344654

ABSTRACT

A 72-year-old man presented for routine dual chamber pacemaker interrogation 13 years following insertion for sick sinus syndrome. Increased noise, impedance and threshold of the right ventricular (RV) lead were identified. RV capture was maintained with an overall RV pacing burden of 47%. A routine generator replacement was scheduled alongside RV lead replacement. Fluoroscopy at the start of the procedure revealed an unexpected striking fracture of the RV pacing lead with complete separation of the proximal and distal portions within the RV. The patient was asymptomatic and described no predisposing factors. He underwent implantation of a new ventricular lead and generator and has remained well. This case demonstrates clear RV lead fracture as a late complication of pacemaker implantation despite maintained capture. This emphasises the need for a chest X-ray when a change in device parameters is noted at device interrogation even in the absence of symptoms.


Subject(s)
Heart Ventricles , Pacemaker, Artificial , Aged , Cardiac Pacing, Artificial , Fluoroscopy , Heart Ventricles/diagnostic imaging , Humans , Male , Myocardium , Sick Sinus Syndrome/therapy
2.
Eur Heart J Cardiovasc Imaging ; 22(10): 1149-1156, 2021 09 20.
Article in English | MEDLINE | ID: mdl-33247898

ABSTRACT

AIMS: Cardiovascular magnetic resonance (CMR) is increasingly recognized as a diagnostic and prognostic tool in out of hospital cardiac arrest (OHCA) survivors. After assessing CMR findings early after ventricular fibrillation (VF) OHCA, we sought to explore the long-term outcome of myocardial scarring and deformation. METHODS AND RESULTS: We included 121 consecutive VF OHCA survivors (82% male, median 62 years) undergoing CMR within 2 weeks from cardiac arrest. Late gadolinium-enhancement (LGE) was quantified using the full width at half maximum method and tissue tracking analysis software was used to assess myocardial deformation. LGE was found in 71% of patients (median LGE mass 6.2% of the left ventricle, LV), mainly with an ischaemic pattern. Myocardial deformation was overall impaired and showed a significant correlation with LGE presence and extent (P < 0.001). A composite end-point of all-cause mortality and appropriate ICD discharge/anti-tachycardia pacing was met in 24% of patients. Patients meeting the end-point had significantly greater LGE extent (8.6% of LV myocardium vs. 4.1%, P = 0.02), while there was no difference with regards to myocardial deformation. Survival rate was significantly lower in patients with LGE (P = 0.05) and LGE mass >4.4% of the LV identified a group of patients at higher risk of adverse events (P = 0.005). CONCLUSIONS: We found a high prevalence of LGE, early after OHCA, and an overall impaired myocardial deformation. On long-term follow-up both LGE presence and extent showed a significant association with recurrent adverse events, while LV ejection fraction and myocardial deformation did not identify patients with an unfavourable outcome.


Subject(s)
Cicatrix , Out-of-Hospital Cardiac Arrest , Cicatrix/diagnostic imaging , Cicatrix/pathology , Contrast Media , Female , Humans , Magnetic Resonance Imaging, Cine , Magnetic Resonance Spectroscopy , Male , Myocardium/pathology , Out-of-Hospital Cardiac Arrest/diagnostic imaging , Out-of-Hospital Cardiac Arrest/therapy , Prognosis , Survivors
3.
J Cardiovasc Electrophysiol ; 31(11): 2948-2953, 2020 11.
Article in English | MEDLINE | ID: mdl-32716096

ABSTRACT

BACKGROUND: A novel active fixation coronary sinus (CS) lead, Attain Stability (AS), has been released aiming to improve targeted lead positioning. Rather than being wedged into the distal vessel, it relies on a side helix for fixation. We aimed to compare implant procedure parameters and electromechanical stability of the AS lead with passive CS leads. METHODS: A retrospective study involving six major UK cardiac centers. Patients who received active fixation leads were compared with passive fixation lead recipients in a 1:2 ratio. The primary outcome was total lead displacements (combined macrodisplacement/microdisplacement, defined as displacements requiring repositioning procedures, an increase in threshold ≥0.5 V or pulse width ≥0.5 ms, or a change in pacing polarity). RESULTS: A total of 761 patients were included (253 AS leads and 508 passive fixation leads), of which 736 had follow-up data. The primary endpoint rate was 31% (75/241) in the active and 43% (214/495) in the passive group (p = .002). Six patients (2.5%) in the active group and 14 patients (2.8%) in the passive group required CS lead repositioning procedures (p = 0.981). On multivariable analysis, active leads were associated with a reduction in lead displacements, odds ratio 0.66 (95% confidence interval: 0.46-0.95), p = .024. There were differences in favor of passive leads in procedure duration, 120 (96-149) versus 127 (105-155) min (p = .008), and fluoroscopy time, 17 (11-26) versus 18.5 (13-27) min (p = .0022). The median follow-up duration was similar (active vs. passive): 31 (17-47) versus 34 (16-71) weeks, (p = .052). CONCLUSION: AS CS leads had improved electromechanical stability compared with passive fixation leads, with only minimal increases in implant procedure and fluoroscopy times.


Subject(s)
Coronary Sinus , Pacemaker, Artificial , Coronary Sinus/diagnostic imaging , Coronary Sinus/surgery , Electrodes, Implanted , Humans , Retrospective Studies , United Kingdom
6.
Europace ; 18(3): 428-35, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26683599

ABSTRACT

AIMS: To assess the usefulness of intrathoracic impedance monitoring (IIM) alerts in guiding empirical treatment of chronic heart failure (CHF) patients to prevent heart failure (HF) hospitalizations and unplanned HF care. METHODS AND RESULTS: Chronic heart failure patients with OptiVol or CorVue capable implantable cardioverter-defibrillators were randomized to either the active group (IIM alarm turned on and diuretic dose increased by 50% for 1 week in the event of alarm sounding) or the control group (IIM alarm turned off). The primary endpoint was the number of HF hospitalizations per patient at 1 year. The NYHA class, 6MWT, B-type natriuretic peptide (BNP), and MLWHF questionnaire score were collected at baseline and follow-up. Eighty patients were included and 71 reached 1-year follow-up. There were 1.7 ± 1.5 alerts in the active group and 1.1 ± 1.0 in the control group, P = 0.07. In the active group, 61% of alerts led to a diuretic dose increase. There was a total of 11 HF hospitalizations in the active group vs. 6 in the control group without significant differences in the number of episodes per patient (0.3 ± 0.9 vs. 0.2 ± 0.4, P = 0.95). There were no unplanned HF visits in the active group vs. 0.1 ± 0.3 per patient in the control group, P = 0.08. The total MLWHF scores were significantly increased at the final follow-up in the control group, whereas a trend towards reduction was observed in the active group. CONCLUSION: In this study, an empirical HF treatment guided by IIM alerts did not reduce emergency treatment of HF. However, it seems to have a positive impact on quality of life. CLINICAL TRIAL REGISTRATIONURL: http://www.clinicaltrials.gov. Unique identifier: NCT01320007.


Subject(s)
Cardiography, Impedance , Defibrillators, Implantable , Electric Countershock/instrumentation , Heart Failure/therapy , Lung/physiopathology , Aged , Aged, 80 and over , Biomarkers/blood , Chronic Disease , Diuretics/administration & dosage , Electric Impedance , Emergency Service, Hospital , Exercise Test , Exercise Tolerance , Female , Heart Failure/diagnosis , Heart Failure/physiopathology , Hospitalization , Humans , London , Male , Middle Aged , Natriuretic Peptide, Brain/blood , Predictive Value of Tests , Prospective Studies , Prosthesis Design , Quality of Life , Surveys and Questionnaires , Time Factors , Treatment Outcome
7.
Pacing Clin Electrophysiol ; 38(10): 1217-22, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26183170

ABSTRACT

BACKGROUND: There is growing interest in detecting paroxysmal atrial fibrillation (PAF) to identify patients at high risk of thromboembolic stroke. The implantable loop recorder (ILR) is emerging as a powerful new tool in the diagnosis of PAF. Widespread implantation has significant cost implications and their use must be targeted at those patients at most risk. METHODS: We retrospectively studied a population of 200 adult patients who underwent ILR implantation for the investigation of syncope or palpitations. Clinical data, baseline electrocardiogram (ECG) characteristics, and echocardiographic data were collected. All ECGs and electrograms (EGMs) were scrutinized by two blinded investigators. PAF incidence was defined as episodes lasting >30 seconds on EGMs recorded in ILR memory. RESULTS: Our ILR population consists of 200 patients, 111 (56%) male, with a mean age of 61.4 years (range 19-95). PAF was detected in 42 patients. The following factors were significant predictors of PAF by multivariate logistic regression analysis: cigarette smoking (odds ratio [OR] = 3.73, 95% confidence interval [CI] = 1.40-10.24, P = 0.009) and incomplete right bundle branch block (IRBBB; OR = 9.04, 95% CI = 2.51-34.64, P = 0.00088). Significant differences included incidence of IRBBB (P = 0.012), cigarette smoking (P = 0.026), hypercholesterolemia (P = 0.015), age (P = 0.002), estimated glomerular filtration rate (P = 0.031), left atrial volume (P = 0.019), and PR interval (P = 0.031). The PAF group had significantly higher CHA2 DS2 -VASc scores (P = 0.01). CONCLUSIONS: Our study reports predictive factors for PAF in an ILR population. We suggest that cigarette smoking and IRBBB are independently associated with paroxysmal AF in patients presenting with palpitations or syncope.


Subject(s)
Atrial Fibrillation/diagnosis , Atrial Fibrillation/epidemiology , Bundle-Branch Block/epidemiology , Electrocardiography, Ambulatory/statistics & numerical data , Information Storage and Retrieval/statistics & numerical data , Smoking/epidemiology , Adult , Aged , Aged, 80 and over , Bundle-Branch Block/diagnosis , Comorbidity , Diagnosis, Computer-Assisted/methods , Diagnosis, Computer-Assisted/statistics & numerical data , Female , Humans , Incidence , Male , Middle Aged , Prognosis , Reproducibility of Results , Retrospective Studies , Risk Factors , Sensitivity and Specificity , United Kingdom/epidemiology
8.
Pacing Clin Electrophysiol ; 38(8): 934-41, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25973599

ABSTRACT

BACKGROUND: Implantable loop recorders (ILR) allow prolonged cardiac rhythm monitoring and improved diagnostic yield in syncope patients. Predictive factors for pacemaker (PM) implantation in the ILR population with unexplained syncope have not been adequately investigated. In this single center, retrospective, observational study we investigated factors that predict PM implantation in this population. METHODS: We retrospectively analyzed our ILR database of patients aged over 18 years who underwent ILR implantation for unexplained syncope between January 2009 and June 2013. Patient case notes were examined for demographics, history, electrocardiogram (ECG) abnormalities, investigations, and events during follow-up. The primary end-point was the detection of a symptomatic or asymptomatic bradycardia requiring PM implantation. RESULTS: During a period of 4.5 years, 200 patients were implanted with ILR for unexplained syncope, of who n = 33 (16.5%) had clinically significant bradycardia requiring PM implantation. After multivariable analysis, history of injury secondary to syncope was found to be the strongest independent predictor for PM implantation (odds ratio [OR]:9.1; P < 0.001; 95% confidence interval [CI]: (3.26-26.81). Other significant predictors included female sex, PR interval > 200msec, and age >75 years. In patients without conduction abnormalities on the ECG, history of injury secondary to syncope was found to be the strongest independent predictor for PM implantation (OR: 8.16; P = 0.00027; 95% [CI]: (2.67-26.27). CONCLUSIONS: A history of injury secondary to syncope and female sex were independent predictive factors for bradycardia necessitating PM implantation in patients receiving an ILR for syncope with or without ECG conduction abnormalities.


Subject(s)
Arrhythmias, Cardiac/therapy , Pacemaker, Artificial , Syncope/therapy , Aged , Arrhythmias, Cardiac/complications , Arrhythmias, Cardiac/physiopathology , Electrocardiography , Female , Humans , Male , Middle Aged , Prognosis , Prosthesis Implantation , Retrospective Studies , Syncope/complications , Syncope/physiopathology
9.
Heart Rhythm ; 12(5): 943-9, 2015 May.
Article in English | MEDLINE | ID: mdl-25638701

ABSTRACT

BACKGROUND: Implantation of a left ventricular (LV) lead fails in 5% to 10% of patients in whom cardiac resynchronization therapy (CRT) is attempted. Alternatives for delivery of CRT are surgical epicardial and endocardial transvenous leads. Endocardial transseptal LV lead delivery is challenging because of the absence of dedicated equipment designed for this procedure. OBJECTIVE: The purpose of this study was to describe a new technique for delivery of a transseptal LV lead. METHODS: This dual approach from the right femoral vein and left subclavian vein involves use of an Endrys transseptal needle and Mullins sheath to deliver a gooseneck snare from the left subclavian vein into the right atrium that can then be used to deliver a deflectable sheath into the left atrium. An active fixation lead is advanced into the LV through the sheath and screwed into the lateral wall. RESULTS: The procedure was performed successfully in 12 patients in whom transvenous LV lead implantation had previously failed. The Endrys transseptal needle, ideally suited for this technique, facilitated passage of the gooseneck snare into the left atrium with no difficulty. Median procedure time was 148 minutes (interquartile range [IQR] 113-176 minutes), and median fluoroscopy time was 16 minutes (IQR 10-19 minutes). There was no need for repeat procedures after median follow-up of 97 days (IQR 36-313 days). CONCLUSION: This approach using an Endrys needle and a gooseneck snare provides a reliable and effective alternative technique for delivery of an endocardial LV lead that is delivered easily through a deflectable sheath inserted transseptally into the LV.


Subject(s)
Cardiac Catheterization , Cardiac Catheters , Cardiac Resynchronization Therapy Devices , Cardiac Resynchronization Therapy , Heart Atria , Heart Failure/therapy , Heart Septum/surgery , Heart Ventricles , Adult , Aged , Aged, 80 and over , Cardiac Catheterization/adverse effects , Cardiac Catheterization/methods , Cardiac Resynchronization Therapy/adverse effects , Cardiac Resynchronization Therapy/methods , Equipment Design , Female , Femoral Vein , Fluoroscopy/methods , Heart Atria/diagnostic imaging , Heart Atria/surgery , Heart Failure/complications , Heart Failure/physiopathology , Heart Ventricles/diagnostic imaging , Heart Ventricles/surgery , Humans , Intraoperative Care/methods , Male , Operative Time , Retrospective Studies , Subclavian Vein , Treatment Outcome , Ventricular Dysfunction, Left/etiology , Ventricular Dysfunction, Left/physiopathology , Ventricular Dysfunction, Left/therapy
10.
Int J Cardiol ; 175(2): 328-32, 2014 Aug 01.
Article in English | MEDLINE | ID: mdl-24985070

ABSTRACT

INTRODUCTION: Stroke associated with atrial fibrillation (AF) is more frequent in heart failure. It is unknown what variables predict future AF in these patients and how AF might evolve over time. We investigated this in patients with implantable cardiac defibrillators (ICD) where AF detection is optimal. METHODS: Single centre, retrospective, observational cohort study. All ischaemic cardiomyopathy patients with dual chamber, primary prevention ICD implants between Aug 2003 and Dec 2009 were screened and included if at implant, they had no known AF history. Nine variables were analysed. AF was defined as any atrial tachyarrhythmia ≥180 bpm and ≥30 s. Multivariable, binary logistic regression models were built by adding variables significant in the univariate models. Variables were retained in the final multivariate models if p<0.05. RESULTS: n=197 met the inclusion criteria (85.8% male, median age: 66.8 years). After median follow-up for 2.8 years, 44.2% developed AF. After univariate analysis, the baseline variables associated with AF after implant were age, NYHA class and renal impairment (RI, defined eGFR<60 ml/min/1.73 m2) (p<0.05). After multivariable analysis, the only variable which was associated with AF was RI (HR: 2.04 (CI: 1.10-3.79)). Two baseline variables were independently associated with all-cause mortality: RI (HR: 2.42 (1.14-5.12)) and non-white ethnicity. CONCLUSION: RI at time of implant was independently associated with both future AF and all-cause mortality during long-term follow-up. RI was a stronger predictor of AF than age. Those patients with heart failure and RI should be regularly screened for asymptomatic AF, regardless of age, to ensure that stroke prophylaxis may be initiated.


Subject(s)
Atrial Fibrillation/diagnosis , Atrial Fibrillation/mortality , Heart Failure/diagnosis , Heart Failure/mortality , Aged , Cohort Studies , Female , Follow-Up Studies , Humans , Male , Middle Aged , Predictive Value of Tests , Retrospective Studies
11.
Circ Arrhythm Electrophysiol ; 7(1): 31-8, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24382410

ABSTRACT

BACKGROUND: Restoring sinus rhythm in patients with heart failure (HF) and atrial fibrillation (AF) may improve left ventricular (LV) function and HF symptoms. We sought to compare the effect of a catheter ablation strategy with that of a medical rate control strategy in patients with persistent AF and HF. METHODS AND RESULTS: Patients with persistent AF, symptomatic HF, and LV ejection fraction <50% were randomized to catheter ablation or medical rate control. The primary end-point was the difference between groups in LV ejection fraction at 6 months. Baseline LV ejection fraction was 32±8% in the ablation group and 34±12% in the medical group. Twenty-six patients underwent catheter ablation, and 24 patients were rate controlled. Freedom from AF was achieved in 21/26 (81%) at 6 months off antiarrhythmic drugs. LV ejection fraction at 6 months in the ablation group was 40±12% compared with 31±13% in the rate control group (P=0.015). Ablation was associated with better peak oxygen consumption (22±6 versus 18±6 mL/kg per minute; P=0.014) and Minnesota living with HF questionnaire score (24±22 versus 47±22; P=0.001) compared with rate control. CONCLUSIONS: Catheter ablation is effective in restoring sinus rhythm in selected patients with persistent AF and HF, and can improve LV function, functional capacity, and HF symptoms compared with rate control. Clinical Trial Registration- URL: http://www.clinicaltrials.gov. Unique identifier: NCT01411371.


Subject(s)
Anti-Arrhythmia Agents/therapeutic use , Atrial Fibrillation/therapy , Catheter Ablation , Heart Failure/complications , Adult , Aged , Anti-Arrhythmia Agents/adverse effects , Atrial Fibrillation/diagnosis , Atrial Fibrillation/etiology , Atrial Fibrillation/physiopathology , Catheter Ablation/adverse effects , Female , Heart Failure/diagnosis , Heart Failure/physiopathology , Humans , London , Male , Middle Aged , Oxygen Consumption/drug effects , Quality of Life , Recovery of Function , Recurrence , Stroke Volume/drug effects , Surveys and Questionnaires , Time Factors , Treatment Outcome , Ventricular Function, Left/drug effects
12.
Heart ; 98(1): 48-53, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21930724

ABSTRACT

OBJECTIVE: To investigate whether catheter ablation of atrial fibrillation (AF) reduces stroke rate or mortality. METHODS: An international multicentre registry was compiled from seven centres in the U.K. and Australia for consecutive patients undergoing catheter ablation of AF. Long-term outcomes were compared with (1) a cohort with AF treated medically in the Euro Heart Survey, and (2) a hypothetical cohort without AF, age and gender matched to the general population. Analysis of stroke and death was carried out after the first procedure (including peri-procedural events) regardless of success, on an intention-to-treat basis. RESULTS: 1273 patients, aged 58±11 years, 56% paroxysmal AF, CHADS(2) score 0.7±0.9, underwent 1.8±0.9 procedures. Major complications occurred in 5.4% of procedures, including stroke/TIA in 0.7%. Freedom from AF following the last procedure was 85% (76% off antiarrhythmic drugs) for paroxysmal AF, and 72% (60% off antiarrhythmic drugs) for persistent AF. During 3.1 (1.0-9.6) years from the first procedure, freedom from AF predicted stroke-free survival on multivariate analysis (HR=0.30, CI 0.16 to 0.55, p<0.001). Rates of stroke and death were significantly lower in this cohort (both 0.5% per patient-year) compared with those treated medically in the Euro Heart Survey (2.8% and 5.3%, respectively; p<0.0001). Rates of stroke and death were no different from those of the general population (0.4% and 1.0%, respectively). CONCLUSION: Restoration of sinus rhythm by catheter ablation of AF is associated with lower rates of stroke and death compared with patients treated medically.


Subject(s)
Atrial Fibrillation/surgery , Catheter Ablation/methods , Stroke/prevention & control , Administration, Oral , Aged , Anticoagulants/administration & dosage , Atrial Fibrillation/drug therapy , Atrial Fibrillation/mortality , Case-Control Studies , Catheter Ablation/mortality , Female , Hemorrhage/chemically induced , Hemorrhage/mortality , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Risk Factors , Stroke/mortality , Treatment Outcome
13.
Circ Arrhythm Electrophysiol ; 4(5): 622-9, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21844156

ABSTRACT

BACKGROUND: Whether ablation of complex fractionated atrial electrograms (CFAE) modifies atrial fibrillation (AF) by eliminating drivers or atrial debulking remains unknown. This randomized study aimed to determine the effect of ablating different CFAE morphologies compared with normal electrograms (ie, debulking normal tissue) on the cycle length of persistent AF (AFCL). METHODS AND RESULTS: After pulmonary vein isolation left and right atrial CFAE were targeted, until termination of AF or abolition of CFAE before DC cardioversion. Ten-second electrograms were classified according to a validated scale, with grade 1 being most fractionated and grade 5 normal. Patients were randomly assigned to have CFAE grades eliminated sequentially, from grade 1 to 5 (group 1) or grade 5 to 1 (group 2). An increase in AFCL (mean of left and right atrial appendage) ≥5 ms after a lesion was regarded as significant. CFAE (n=968) were targeted in 20 patients. AFCL increased after targeting 51±35% of grade 1 CFAE, 30±15% grade 2, 12±5% grade 3, 33±12% grade 4, and 8±15% grade 5 CFAE (P<0.01 for grades 1, 2, and 4 versus 5; 3 versus 5, not significant). The proportion of lesions causing AFCL prolongation was unaffected by the order in which CFAE were targeted. CONCLUSIONS: Targeting CFAE is not simply atrial debulking. Ablating certain grades of CFAE increases AFCL, suggesting they are more important in maintaining AF. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00894400.


Subject(s)
Atrial Fibrillation/surgery , Catheter Ablation/methods , Electrophysiologic Techniques, Cardiac , Heart Atria/physiopathology , Aged , Atrial Fibrillation/physiopathology , Female , Heart Atria/surgery , Humans , Male , Middle Aged , Observer Variation , Pulmonary Veins/surgery , Time Factors , Treatment Outcome
14.
Heart ; 97(17): 1410-6, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21700757

ABSTRACT

OBJECTIVE: To determine the value of echocardiography in predicting response to cardiac resynchronisation therapy (CRT). METHODS: This is a prospective randomised study that recruited patients with (group 1) and without (group 2) echocardiographic evidence of mechanical dyssynchrony. 73 heart failure patients (NYHA III-IV) with a requirement for an implantable cardioverter defibrillator, QRS ≥120 ms and LV ejection fraction (EF) <35% were studied. Group 1 patients received CRT-D (26 patients). Group 2 patients were randomised to CRT-D (group 2a: 23 patients) or implantable cardioverter defibrillator (group 2b: 21 patients). MAIN OUTCOME MEASURES: were peak oxygen consumption (VO(2)max), NYHA class, and echocardiography at baseline and at 6 months. RESULTS: 62% of group 1 patients achieved ≥1 ml/kg/min increase in VO(2)max at 6 months versus 50% in group 2a and 21% in group 2b (p=0.04). Group 1 patients showed significant improvements in VO(2)max (15.8±2 to 18.0±4 ml/kg/min, p=0.01), NYHA class (3.1±0.3 to 1.9±0.7, p<0.001) and EF (22±7% to 26±9%, p=0.02). Group 2a showed significant improvement in NYHA class (3.1±0.3 to 2.2±0.7, p<0.001) but no change in EF or VO(2)max. Group 2b showed no change in NYHA class or EF with a decline in VO(2)max (16.4±4 to 14.1±4, p=0.03). A significantly higher proportion of patients in group 2b showed ≥1 ml/kg/min deterioration in VO(2)max compared to group 2a (68% vs 23%, HR for group 2b: 2.4, 95% CI 1.2 to 4.8, p=0.005). CONCLUSIONS: The presence of echocardiographic dyssynchrony identifies patients who derive the most improvement from CRT. Patients without dyssynchrony also show more benefit and less deterioration with CRT than without and should not be denied CRT.


Subject(s)
Cardiac Resynchronization Therapy , Heart Failure/diagnostic imaging , Heart Failure/therapy , Ventricular Dysfunction, Left/diagnostic imaging , Aged , Defibrillators, Implantable , Double-Blind Method , Echocardiography , Female , Heart Failure/physiopathology , Humans , Male , Middle Aged , Observer Variation , Predictive Value of Tests , Prospective Studies , Ventricular Dysfunction, Left/physiopathology
15.
Europace ; 12(12): 1691-7, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20823042

ABSTRACT

AIMS: To investigate the impact of variant pulmonary vein (PV) anatomy and the use of three-dimensional image integration (3D-II) on long-term efficacy of catheter ablation for atrial fibrillation (AF). METHODS: Consecutive procedures from 2002 to 2007 were analysed from a prospective database. All patients underwent wide area circumferential ablation, with linear lesions added and complex fractionated electrograms targeted for persistent AF. Imaging was segmented on Carto to assess PV anatomy. RESULTS: Three hundred and fifty patients underwent 1.9 ± 0.9 procedures. The mean age was 57 ± 11 years, 73% males, and 55% paroxysmal AF. Freedom from AF/atrial tachycardia was 42% for paroxysmal AF and 20% for persistent AF at 3.1 years after the first procedure, or 86 and 66%, respectively, at 2.5 years after the last procedure. The Kaplan-Meier analysis showed a trend towards improved single-procedure efficacy with 3D-II (8.9% difference, P = 0.087) and a reduction in the number of procedures per patient from 2.1 ± 1.1 to 1.8 ± 0.9 (P < 0.0001). The use of 3D-II improved single-procedure efficacy with Carto (13.3% difference, P = 0.018), but not with Ensite NavX. Variant PV anatomy was identified in 28% and was associated with a lower single-procedure efficacy (10.0% difference, P = 0.024) but with no effect on final outcome. Multivariate analysis confirmed the impact of 3D-II [hazard ratio (HR) for recurrence of AF 0.67, P = 0.020] and variant PV anatomy (HR 1.37, P = 0.044). CONCLUSION: The use of 3D-II improves single-procedure efficacy of PV isolation for AF. Variant PV anatomy was associated with a lower single-procedure success rate.


Subject(s)
Atrial Fibrillation/diagnosis , Atrial Fibrillation/surgery , Catheter Ablation/methods , Imaging, Three-Dimensional/methods , Pulmonary Veins/pathology , Aged , Atrial Fibrillation/mortality , Female , Follow-Up Studies , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Multivariate Analysis , Prognosis , Prospective Studies , Retrospective Studies , Treatment Outcome
16.
Europace ; 11(12): 1587-96, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19897499

ABSTRACT

AIMS: We tested application of a grading system describing complex fractionated electrograms (CFE) in atrial fibrillation (AF) and used it to validate automated CFE detection (AUTO). METHODS AND RESULTS: Ten seconds bipolar electrograms were classified by visual inspection (VI) during ablation of persistent AF and the result compared with offline manual measurement (MM) by a second blinded operator: Grade 1 uninterrupted fractionated activity (defined as segments > or =70 ms) for > or =70% of recording and uninterrupted > or =1 s; Grade 2 interrupted fractionated activity > or =70% of recording; Grade 3 intermittent fractionated activity 30-70%; Grade 4 discrete (<70 ms) complex electrogram (> or =5 direction changes); Grade 5 discrete simple electrograms (< or =4 direction changes); Grade 6 scar. Grade by VI and MM for 100 electrograms agreed in 89%. Five hundred electrograms were graded on Carto and NavX by VI to validate AUTO in (i) detection of CFE (grades 1-4 considered CFE), and (ii) assessing degree of fractionation by correlating grade and score by AUTO (data shown as sensitivity, specificity, r): NavX 'CFE mean' 92%, 91%, 0.56; Carto 'interval confidence level' using factory settings 89%, 62%, -0.72, and other published settings 80%, 74%, -0.65; Carto 'shortest confidence interval' 74%, 70%, 0.43; Carto 'average confidence interval' 86%, 66%, 0.53. CONCLUSION: Grading CFE by VI is accurate and correlates with AUTO.


Subject(s)
Algorithms , Atrial Fibrillation/classification , Atrial Fibrillation/diagnosis , Body Surface Potential Mapping/methods , Diagnosis, Computer-Assisted/methods , Electrocardiography/methods , Pattern Recognition, Automated/methods , Female , Humans , Male , Middle Aged , Observer Variation , Reproducibility of Results , Sensitivity and Specificity , Statistics as Topic
18.
Br J Hosp Med (Lond) ; 68(5): 257-62, 2007 May.
Article in English | MEDLINE | ID: mdl-17554951

ABSTRACT

This is the third in a series of four practical articles highlighting the important management steps for non-cardiologists and non-cardiac electrophysiologists dealing with patients with atrial fibrillation and common atrial flutter. This article will deal with care pathways and management principles for paroxysmal atrial fibrillation.


Subject(s)
Atrial Fibrillation/therapy , Anti-Arrhythmia Agents/therapeutic use , Atrial Fibrillation/diagnosis , Atrial Fibrillation/etiology , Catheter Ablation/methods , Defibrillators, Implantable , Humans , Long-Term Care , Pacemaker, Artificial , Stroke/prevention & control
19.
Br J Hosp Med (Lond) ; 68(4): 201-4, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17465101

ABSTRACT

This is the second in a series of four practical articles highlighting the important management steps for noncardiologists and non-cardiac electrophysiologists dealing with patients with atrial fibrillation and common atrial flutter. This article will deal with care pathways and management principles for common atrial flutter.


Subject(s)
Atrial Flutter/therapy , Atrial Flutter/diagnosis , Atrial Flutter/mortality , Catheter Ablation/methods , Electrophysiology , Humans
20.
Br J Hosp Med (Lond) ; 68(3): 122-5, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17419458

ABSTRACT

This is the first in a series of four practical articles highlighting the important management steps for non-cardiologists and non-cardiac electrophysiologists dealing with patients with atrial fibrillation and common atrial flutter. This article will deal with care pathways and management principles for cardioversion of atrial arrhythmias.


Subject(s)
Anti-Arrhythmia Agents/therapeutic use , Arrhythmias, Cardiac/therapy , Electric Countershock/methods , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...